Dabrafenib Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with dabrafenib
J
- J-Cof DHC (brompheniramine / dihydrocodeine / pseudoephedrine)
- J-Max DHC (dihydrocodeine / guaifenesin)
- J-Tan D HC (brompheniramine / hydrocodone / pseudoephedrine)
- Jaimiess (ethinyl estradiol / levonorgestrel)
- Jakafi (ruxolitinib)
- Jalyn (dutasteride / tamsulosin)
- Jantoven (warfarin)
- Janumet (metformin / sitagliptin)
- Janumet XR (metformin / sitagliptin)
- Januvia (sitagliptin)
- Jasmiel (drospirenone / ethinyl estradiol)
- Jatenzo (testosterone)
- JayCof-HC (chlorpheniramine / hydrocodone / pseudoephedrine)
- Jaypirca (pirtobrutinib)
- Jencycla (norethindrone)
- Jenest (ethinyl estradiol / norethindrone)
- Jentadueto (linagliptin / metformin)
- Jentadueto XR (linagliptin / metformin)
- Jevantique (ethinyl estradiol / norethindrone)
- Jevantique Lo (ethinyl estradiol / norethindrone)
- Jevtana (cabazitaxel)
- Jinteli (ethinyl estradiol / norethindrone)
- Joenja (leniolisib)
- Jolessa (ethinyl estradiol / levonorgestrel)
- Jolivette (norethindrone)
- Joyeaux (ethinyl estradiol / levonorgestrel)
- Juleber (desogestrel / ethinyl estradiol)
- Julie (levonorgestrel)
- Juluca (dolutegravir / rilpivirine)
- Jumex (selegiline)
- Junel 1.5 / 30 (ethinyl estradiol / norethindrone)
- Junel 1 / 20 (ethinyl estradiol / norethindrone)
- Junel Fe 1.5 / 30 (ethinyl estradiol / norethindrone)
- Junel Fe 1 / 20 (ethinyl estradiol / norethindrone)
- Junel Fe 24 (ethinyl estradiol / norethindrone)
- Juvederm Ultra Plus XC (hyaluronan / lidocaine)
- Juvisync (simvastatin / sitagliptin)
- Juxtapid (lomitapide)
- Jynarque (tolvaptan)
More about dabrafenib
- dabrafenib consumer information
- Check interactions
- Compare alternatives
- Reviews (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.